Back to results

$15.2M Valsartan, Losartan and Irbesartan class action settlement

via Top Class Actions Published: Apr 20, 2026

Summary

Aurobindo, Hetero and Vivimed agreed to settlements totaling more than $15.2 million over claims their blood pressure medications were contaminated with cancer-causing substances.... Read More The post $15.2M Valsartan, Losartan and Irbesartan class action settlement appeared first on Top Class Actions.

Read full article →